Functional enrichment analyses further suggested that EIF2B4 may drive HCC progression via dual mechanisms: directly accelerating tumor cell cycle progression through translation reprogramming, and shaping an immunosuppressive microenvironment via aberrant synthesis of immune-modulatory molecules. The gene discussed is EIF2B4; the disease is neoplasm.